Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma or the oesophagus

Journal of Clinical Pathology

Volumn 58, Issue 9, 2005, Pages 904-910

  Yamazaki, K ^a   Hasegawa, M ^a   Ohoka, I ^a   Hanami, K ^b   Asoh, A ^a   Nagao, T ^c   Sugano, I ^a   Ishida, Y ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TRANSCRIPTION FACTOR E2F1;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 24644501329     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.023127     Document Type: Article

References (33)

1. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-77.
2. Hiebert SW, Chellappan SP, Horowitz JM, et al. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1992;6:177-85.
3. Helin K, Wu CL, Fattaey AR, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 1993;7:1850-61.
4. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 1998;8:28-35.
5. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998;12:2245-62.
6. Ginsberg D, Vairo G, Chittenden T, et al. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 1994;8:2665-79.
7. Johnson DG, Schwarz JK, Cress WD, et al. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993;365:349-52.
8. Johnson DG, Cress WD, Jakoi L, et al. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 1994;91:12823-7.
9. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, et al. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A 1998;95:8858-63.
10. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996;85:549-61.
11. Zacharatos P, Kotsinas A, Evangelou K, et al. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol 2004;203:744-53.
12. DeGregori J, Leone G, Miron A, et al. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A 1997;94:7245-50.
13. Tsai KY, Hu Y, Macleod KF, et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 1998;2:293-304.
14. Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, et al. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 1999;19:6408-14.
15. Nicholson SA, Okby NT, Khan MA, et al. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Res 2001;61:5636-43.
16. Yamasaki L, Jacks T, Bronson R, et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996;85:537-48.
17. Yamasaki L, Bronson R, Williams BO, et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat Genet 1998;18:360-4.
18. Rabbani F, Richon VM, Orlow I, et al. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 1999;91:874-81.
19. Kwong RA, Nguyen TV, Bova RJ, et al. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 2003;9:3705-11.
20. Zhang SY, Liu SC, Al-Saleem LF, et al. E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 2000;9:395-401.
21. Gorgoulis VG, Zacharatos P, Mariatos G, et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002;198:142-56.
22. Yamazaki K, Yajima T, Nagao T, et al. Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. Pathol Res Pract 2003;199:23-8.
23. Ikeda G, Isaji S, Chandra B, et al. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999;86:1396-405.
24. Matsumoto M, Natsugoe S, Nakashima S, et al. Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. Ann Surg Oncol 2001;8:598-604.
25. Shibata H, Matsubara O. Apoptosis as an independent prognostic indicator in squamous cell carcinoma of the esophagus. Pathol Int 2001;51:498-503.
26. Hasegawa M, Ohoka I, Yamazaki K, et al. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002;52:442-50.
27. Natsugoe S, Nakashima S, Matsumoto M, et al. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 1999;5:2445-9.
28. Guner D, Sturm I, Hemmati P, et al. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 2003;103:445-54.
29. Suzuki T, Yasui W, Yokozaki H, et al. Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer 1999;81:535-8.
30. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721-8.
31. Zhou XB, Guo M, Quan LP, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003;9:1170-3.
32. Smeds J, Berggren P, Ma X, et al. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation. Carcinogenesis 2002;23:645-55.
33. Yang HL, Dong TB, Elliott ML, et al. Caspase activation and changes in Bcl-s family member protein expression associated with E2F-1 mediated apoptosis in human esophageal cancer. Clin Cancer Res 2000;6:1579-89.